Sarepta Soars After Positive Results In DMD Treatment Study

By: via Benzinga
Sarepta Therapeutics Inc (NASDAQ: SRPT) shares are trading higher by $5.75, or 14 percent, at $46.83 in Wednesday's session. The ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.